Our goal is to provide faster and easier access to accurate and objective educational materials and resources to help men and their spouses/partners and families make informed decisions about prostate cancer detection, treatment options and related side effects.
We all know that knowledge is power. Knowledge begins with awareness and basic information about prostate cancer including prevalence, high-risk populations, testing, diagnosis, and treatment. Every man has a responsibility to take control of managing his care to ensure that he’s not over-treated or under-treated. And the information required to effectively manage prostate cancer can be much more extensive than what might be needed for managing many other diseases. In addition to active surveillance or watchful waiting as potential options, there are several types of treatments and multiple therapies and combinations available to eliminate or manage the disease. It’s also important to recognize that any treatment will have side effects. The extent to which they are present, their duration, and overall impact on quality of life will vary for each man.
We hope that you find this website helpful as a valuable resource that you can count on to provide the information and perspective that you need through educational materials available electronically and in print, support groups, newsletters, relevant news articles, 800-number HelpLine, an on-line community, email groups, educational events and conferences across the country. As is the nature of any relevant website, know that this website will be in a state of perpetual “work-in-progress” with updates being made as needed to reflect the most recent information available. Please let us know if you have any suggestions or comments.
On behalf of those we serve in the prostate cancer community with the services and materials that we provide at no charge, we would like to thank all of our corporate sponsors and individual donors. We would like to especially thank the following companies that supported the redesign and update of this website: Astellas/Medivation, Dendreon, AMGEN, AbbVie.
Our best regards,